FDA
-
-
-
-
-
-
-
Medicus Pharma submits rare pediatric disease designation request for SkinJect
-
-
-
-
-
-
-
Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome
-
-
-
-
-
-
-
Medicus Pharma reports validation of SkinJect skin cancer trial data
-
-
-
-
-
-
-
Medicus Pharma schedules webcast with Phase 2 trial investigator
-
-
-
-
-
-
-
Medicus Pharma To Participate in the 38th Annual Roth Conference
-
-
-
-
-
-
-
Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026
-
329,911 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

